BioTrak Therapeutics
Boulder
About BioTrak Therapeutics
BioTrak is digital therapeutics platform company with smartphone products which deliver evidence-based, preventative treatment of stress-related disorders such as migraine, multiple sclerosis, depression, chronic pain, and anxiety. The first of a series of products is Ease: Headache and Migraine™, which was launched Q1’ 19. Three (3) billion people worldwide suffer from severe tension-type headaches and migraine. Ease, which delivers clinically-tested behavioral interventions on a mobile platform, is superior in clinical effectiveness, safety, cost, and convenience compared to the most advanced migraine drugs. Ease is positioned to be used either alone or adjunctively with conventional drug therapies. Ease: Headache & Migraine™ is digital therapeutic app that delivers clinically-proven, effective behavioral therapy. Ease has been shown to be as effective as in-office treatment, resulting in 60% reduction in headache frequency and disability. Ease is a brand new approach to addressing the severely unmet need for a scalable, affordable, safe and effective treatment option for the estimated 3 billion people who suffer from tension headache and migraine worldwide.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Last round: Non-Equity Assistance (May 2018)
- Website: biotraktherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Internet of Things, mHealth, Mobile Apps
Social Profiles
Canonical: https://fsome.com/organization/biotrak-therapeutics-857947 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.